References
<A NAME="RD19311ST-1A">1a</A>
Mehta G.
Srikrishna A.
Chem.
Rev.
1997,
97:
671
<A NAME="RD19311ST-1B">1b</A>
Singh V.
Thomas B.
Tetrahedron
1998,
54:
3647
For example, siliphiperfol-6-ene - isolation:
<A NAME="RD19311ST-2A">2a</A>
Bohlmann F.
Jakupovic J.
Phytochemistry
1980,
19:
259
Synthesis - in racemic form:
<A NAME="RD19311ST-2B">2b</A>
Reddy TJ.
Rawal VH.
Org.
Lett.
2000,
2:
2711
<A NAME="RD19311ST-2C">2c</A>
Kakiuchi K.
Ue M.
Tsukahara H.
Shimizu T.
Miyao T.
Tobe Y.
Odaira Y.
Yasuda M.
Shima K.
J. Am. Chem. Soc.
1989,
111:
3707
<A NAME="RD19311ST-2D">2d</A>
Curran DP.
Kuo SC.
Tetrahedron
1987,
43:
5653
<A NAME="RD19311ST-2E">2e</A>
Wender PA.
Singh SK.
Tetrahedron
Lett.
1985,
26:
5987
In enantioselective manner:
<A NAME="RD19311ST-2F">2f</A>
Sha CK.
Santhosh KC.
Lih S.-H.
J.
Org. Chem.
1998,
63:
2699
<A NAME="RD19311ST-2G">2g</A>
Vo NH.
Snider BB.
J. Org. Chem.
1994,
59:
5419
<A NAME="RD19311ST-2H">2h</A>
Dickson JK.
Fraser-Reid B.
J.
Chem. Soc., Chem. Commun.
1990,
1440
<A NAME="RD19311ST-2I">2i</A>
Meyers AI.
Lefker BA.
Tetrahedron
1987,
43:
5663
<A NAME="RD19311ST-2J">2j</A>
Paquette LA.
Roberts RA.
Drtina GJ.
J. Am. Chem. Soc.
1984,
106:
6690
Cameroonanol(isolation):
<A NAME="RD19311ST-3A">3a</A>
Weyerstahl P.
Marschall H.
Seelmann I.
Jakupovic J.
Eur. J. Org. Chem.
1998,
1205
Synthesis - in enantioselective manner:
<A NAME="RD19311ST-3B">3b</A>
Taber DF.
Nelson CG.
J.
Org. Chem.
2011,
76:
1874
In racemic form:
<A NAME="RD19311ST-3C">3c</A>
Schmidt AW.
Olpp T.
Schmid S.
Jager A.
Knolker H.-J.
Tetrahedron
2009,
65:
5484
<A NAME="RD19311ST-3D">3d</A>
Davis CE.
Duffy BC.
Coates RM.
J. Org. Chem.
2003,
68:
6935
<A NAME="RD19311ST-4A">4a</A>
Ye T.
McKervey MA.
Chem.
Rev.
1994,
94:
1091
<A NAME="RD19311ST-4B">4b</A>
Doyle MP. In Comprehensive Organometallic Chemistry
II
Vol. 12:
Hegedus LS.
Pergamon
Press;
New York:
1995.
Chap. 5.2.
<A NAME="RD19311ST-4C">4c</A>
Doyle MP.
McKervey MA.
Ye T.
Modern Catalytic Methods
for Organic Synthesis with Diazo Compounds: From
Cyclopropanes to Ylides
John Wiley and Sons;
New
York:
1998.
Chap. 3.
<A NAME="RD19311ST-5A">5a</A>
Srikrishna A.
Babu NC.
Tetrahedron
Lett.
2001,
42:
4913
<A NAME="RD19311ST-5B">5b</A>
Srikrishna A.
Babu NC.
Dethe DH.
Indian
J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.
2003,
42:
1688
<A NAME="RD19311ST-5C">5c</A>
Srikrishna A.
Dethe DH.
Org. Lett.
2003,
5:
2295
<A NAME="RD19311ST-5D">5d</A>
Srikrishna A.
Babu NC.
Rao MS.
Tetrahedron
2004,
60:
2125
<A NAME="RD19311ST-5E">5e</A>
Srikrishna A.
Pardeshi VH.
Satyanarayana G.
Tetrahedron: Asymmetry
2010,
21:
746
<A NAME="RD19311ST-5F">5f</A>
Srikrishna A.
Pardeshi VH.
Tetrahedron
2010,
66:
6810
<A NAME="RD19311ST-5G">5g</A>
Srikrishna A.
Pardeshi VH.
Mahesh K.
Tetrahedron:
Asymmetry
2010,
21:
2512
<A NAME="RD19311ST-5H">5h</A>
Srikrishna A.
Pardeshi VH.
Mahesh K.
Tetrahedron:
Asymmetry
2010,
21:
2830
<A NAME="RD19311ST-5I">5i</A>
Srikrishna A.
Nagaraju G.
Ravi G.
Synlett
2010,
3015
<A NAME="RD19311ST-5J">5j</A>
Srikrishna A.
Dethe DH.
Indian J. Chem., Sect.
B: Org. Chem. Incl. Med. Chem.
2011,
50:
1092
<A NAME="RD19311ST-6">6</A>
Johnson WS.
Werthemann L.
Bartlett WR.
Brocksom TJ.
Li T.-t.
Faulkner DJ.
Petersen R.
J.
Am. Chem. Soc.
1970,
92:
741
<A NAME="RD19311ST-7A">7a</A>
Stork G.
Ficini J.
J.
Am. Chem. Soc.
1961,
83:
4678
<A NAME="RD19311ST-7B">7b</A>
Burke SD.
Grieco PA.
Org.
React.
1979,
26:
361
<A NAME="RD19311ST-7C">7c</A>
Mander LN.
Synlett
1991,
134
<A NAME="RD19311ST-7D">7d</A>
Padwa A.
Krumpe KE.
Tetrahedron
1992,
48:
5385
<A NAME="RD19311ST-8A">8a</A>
Norin T.
Acta Chem. Scand.
1963,
17:
738
<A NAME="RD19311ST-8B">8b</A>
Norin T.
Acta
Chem. Scand.
1965,
19:
1289
<A NAME="RD19311ST-8C">8c</A>
Dauben WG.
Deviny EJ.
J.
Org. Chem.
1966,
31:
3794
<A NAME="RD19311ST-8D">8d</A>
Dauben WG.
Wolf RE.
J.
Org. Chem.
1970,
35:
374
<A NAME="RD19311ST-8E">8e</A>
Dauben WG.
Wolf RE.
J.
Org. Chem.
1970,
35:
2361
<A NAME="RD19311ST-8F">8f</A>
Srikrishna A.
Krishnan K.
Yelamaggad CV.
Tetrahedron
1992,
48:
9725
<A NAME="RD19311ST-9">9</A>
Yields refer to isolated and chromatographically
pure compounds. All the compounds exhibited spectroscopic data (IR, ¹H
and ¹³C NMR, and HRMS) consistent with
their structures.
Selected Spectral
Data1-{(1
S
,2
R
,5
S
)-1,5-Dimethylbicyclo[3.3.0]octane-spiro[7.2′]-1,3-dioxolan-2-yl}ethanone (17)
[α]D
²² -69.6
(c 2.1, CHCl3). IR (neat): νmax = 2959,
2879, 1708 (C=O), 1452, 1354, 1331, 1238, 1161, 1114, 1091, 1070,
1040, 1019, 946, 894, 820, 727 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 3.95-3.65
(4 H, m, OCH2CH2O), 3.15 (1 H, dd, J = 9.2, 8.0 Hz), 2.24 (1 H,
d, J = 14.4 Hz), 2.09 (3 H, s,
CH3C=O), 2.10-1.45 (7 H, m), 0.94 (3
H, s), 0.74 (3 H, s, 2 × tert-CH3). ¹³C
NMR (100 MHz, CDCl3): δ = 209.9 (C, C=O),
116.3 (C, C-7), 64.0 (CH2), 63.7 (CH2) [OCH2CH2O], 61.0
(CH, C-2), 52.1 (C), 51.4 (C), 50.7 (CH2), 49.6 (CH2, C-4),
37.8 (CH2), 31.3 (CH3, CH3C=O),
24.4 (CH2, C-3), 23.4 (CH3), 18.5 (CH3).
HRMS: m/z calcd for C14H22O3Na [M + Na]:
261.1467; found: 261.1465.
Ethyl 2-Diazo-3-{(1
S
,2
R
,5
S
)-1,5-dimethylbicyclo-[3.3.0]octane-spiro[7.2′]-1,3-dioxolan-2-yl}-3-oxopropanoate
(19)
[α]D
²5 -50.9
(c 3.0, CHCl3). IR (neat): νmax = 2960,
2878, 2136 (N=N), 1715 (OC=O), 1652 (C=O),
1470, 1455, 1378, 1334, 1301, 1206, 1116, 1092, 1043, 1020 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 4.29 (2 H,
q, J = 7.1 Hz, OCH
2CH3), 4.02 (1
H, dd, J = 7.8, 7.1 Hz), 3.95-3.75
(4 H, m, OCH2CH2O), 2.21 (1 H, d, J = 14.2 Hz), 2.15-2.06
(1 H, m), 1.98 (1 H, d, J = 14.1
Hz), 1.92 (1 H, d, J = 14.9
Hz), 1.90-1.66 (4 H, m), 1.32 (3 H, t, J = 7.1
Hz, OCH2CH
3), 1.01
(3 H, s), 0.91 (3 H, s, 2 × tert-CH3). ¹³C
NMR (100 MHz, CDCl3): δ = 195.0 (C,
C=O), 161.3 (C, OC=O), 116.4 (C, OCO), 64.1 (C,
C=N2), 64.0 (CH2), 63.8 (CH2,
OCH2CH2O], 61.2 (CH2,
OCH2CH3), 56.4
(CH), 53.6 (C), 52.3 (CH2), 51.2 (C), 49.9 (CH2),
39.9 (CH2), 26.7 (CH2), 23.1 (CH3), 19.9
(CH3), 14.4 (CH3, OCH2
CH3). HRMS: m/z calcd
for C17H24N2O5Na [M + Na]:
359.1583; found: 359.1579
(1
S
,5
R
,8
S
)-8-Methyltricyclo[6.3.0.0
¹,5
]undecane-4,10-dione (21)
mp 147-149 ˚C; [α]D
²² +62.6
(c 2.5, CHCl3). IR (neat): νmax = 2961,
2875, 1736 (C=O), 1405, 1272, 1227, 1178, 735 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 2.61 (1 H,
d, J = 18.7 Hz), 2.50-2.27
(4 H, m), 2.24 (2 H, s), 2.20-1.95 (2 H, m), 1.94-1.55
(4 H, m), 1.14 (3 H, s, tert CH3). ¹³C
NMR (100 MHz, CDCl3 + CCl4): 220.7
(C, C=O), 217.0 (C, C=O), 58.7 (CH, C-5), 57.3
(C, C-1), 51.2 (CH2), 50.2 (C, C-8), 50.1 (CH2),
39.8 (CH2), 37.7 (CH2), 29.2 (CH2),
26.7 (CH2), 21.5 (CH3, tert CH3).
HRMS: m/z calcd for C12H16O2Na [M + Na]:
215.1060; found: 215.1048
(1
S
,5
S
,8
S
)-4,10-Bismethylene-8-methyltricyclo-[6.3.0.0
¹,5
]dodecane (22)
[α]D
²4 -35.7
(c 1.0, CHCl3). IR (neat): νmax = 3072,
2947, 2862, 1654, 1464, 1456, 1375, 1210, 879 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 4.82 (1 H,
s), 4.76 (1 H, s), 4.75 (1 H, s), 4.72 (1 H, s, 2 × C=CH2),
2.51 (1 H, d, J = 8.8 Hz), 2.40
(1 H, d, J = 15.4 Hz), 2.37-2.29
(2 H, m), 2.25 and 2.18 (2 H, 2 × d, J = 16.4 Hz), 2.10-1.88
(1 H, m), 1.68 (1 H, td, J = 12.4,
8.4 Hz), 1.65-1.35 (5 H, m), 1.00 (3 H, s, tert CH3). ¹³C
NMR (100 MHz, CDCl3): δ = 159.0 (C,
C-4), 151.4 (C, C-10), 105.1 (CH2), 104.4 (CH2,
2 × C=CH2),
62.9 (C, C-1), 56.2 (CH, C-5), 51.3 (C, C-8), 47.5 (CH2),
46.2 (CH2), 39.9 (CH2), 35.2 (CH2),
33.5 (CH2), 31.6 (CH2), 23.3 (CH3). HRMS: m/z calcd for C14H20Na [M + Na]:
211.1463; found: 211.1475.
<A NAME="RD19311ST-10">10</A>
Krapcho AP.
Synthesis
1982,
893